BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 5768460)

  • 1. Serum growth hormone levels and the response of diabetic retinopathy to pituitary ablation.
    Wright AD; Kohner EM; Oakley NW; Hartog M; Joplin GF; Fraser TR
    Br Med J; 1969 May; 2(5653):346-8. PubMed ID: 5768460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Trial treatment of diabetic retinopathy by inhibition of pituitary somatotropin secretion with MAP].
    Bruni B; Bruni-Bocher K; Della Valle A; Gamba S
    Minerva Med; 1975 Mar; 66(21):1001-23. PubMed ID: 1124148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypophysectomy in diabetic retinopathy. The relationship between the degree of pituitary ablation and ocular response.
    Adams DA; Rand RW; Roth NH; Dashe AM; Gipstein RM; Heuser G
    Diabetes; 1974 Aug; 23(8):698-707. PubMed ID: 4604549
    [No Abstract]   [Full Text] [Related]  

  • 4. The rate of formation and disapearance of microaneurysms i diabetic retinopathy.
    Kohner EM; Dollery CT
    Eur J Clin Invest; 1970 Nov; 1(3):167-71. PubMed ID: 5497219
    [No Abstract]   [Full Text] [Related]  

  • 5. Pituitary ablation by 90 yttrium implantation for advancing diabetic retinopathy. A preliminary report.
    Cullen JF; Harris P; Turner JW; Donaldson AA; Munro JF; Duncan LJ
    Br J Ophthalmol; 1965 Aug; 49(8):405-12. PubMed ID: 5826892
    [No Abstract]   [Full Text] [Related]  

  • 6. Proceedings: Pituitary function after yttrium-90 hypophysectomy.
    Wilson RG; Buchan B; Forrest AP; Boyns AR; Cole EN; Griffiths K
    Br J Surg; 1974 Apr; 61(4):322. PubMed ID: 4832652
    [No Abstract]   [Full Text] [Related]  

  • 7. Pituitary ablation for diabetic retinopathy. II. Results of yttrium 90 implantation in the pituitary gland.
    Ray BS; Pazianos AG; Greenberg E; Peretz WL; McLean JM
    JAMA; 1968 Jan; 203(2):85-7. PubMed ID: 4864333
    [No Abstract]   [Full Text] [Related]  

  • 8. Pituitary function after yttrium implants as measured by plasma growth hormone levels.
    Stewart HJ; Benson EA; Roberts MM; Forrest AP; Greenwood FC
    J Endocrinol; 1971 May; 50(1):41-50. PubMed ID: 5580827
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of patients for yttrium-90 implantation of the pituitary gland.
    Whitwam JG; Tunbridge WM; Fuller WI
    Br J Anaesth; 1973 Nov; 45(11):1121-9. PubMed ID: 4786997
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of yttrium-90 implantation on endocrine function and visual fields in patients with "functionless" pituitary tumors, with biopsy and radiological findings.
    Joplin GF; Jackson RA; Arnot RN; Burke CW; Doyle FH; Harsoulis P; Lewis PD; Macerlean DP; Marshall JC; Van Noorden S; Fraser TR
    Clin Endocrinol (Oxf); 1975 Mar; 4(2):139-63. PubMed ID: 165914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metabolic changes following irradiation of the pituitary gland with yttrium isotopes for diabetic retinopathy].
    Dub O; Pátek F
    Vnitr Lek; 1969 Nov; 15(11):1082-8. PubMed ID: 5364828
    [No Abstract]   [Full Text] [Related]  

  • 12. [Destruction of the pituitary gland by intrasellar implantation of radioactive yttrium in the treatment of diabetic retinopathy].
    Dogliotti GC; Molinatti GM; Camanni F; Losana O; Massara F
    Minerva Med; 1968 May; 59(43):2505-12. PubMed ID: 5664429
    [No Abstract]   [Full Text] [Related]  

  • 13. Pituitary ablation by yttrium-90 implants for diabetic retinopathy.
    FRASER R; JOPLIN GF; STEINER RE
    Diabetes; 1962; 11():482-3. PubMed ID: 13959343
    [No Abstract]   [Full Text] [Related]  

  • 14. GROWTH HORMONE AND DIABETES MELLITUS.
    GREENBERG E
    Diabetes; 1965 Jan; 14():43-5. PubMed ID: 14260100
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the progress of flat new vessels on the optic disc with those on the retina in patients treated by pituitary ablation.
    Elkeles RS; Blach RK; Joplin GF
    Diabetologia; 1971 Apr; 7(2):102-6. PubMed ID: 5581538
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ophthalmologic indications and results of stereo-GIHF in diabetic retinopathy. 2].
    Debry G; Schaub C; Drouin P; Szikla ; Saudax E; Boujard O; Talairach J
    Neurochirurgie; 1977 Jul; 23(2):97-109. PubMed ID: 562480
    [No Abstract]   [Full Text] [Related]  

  • 17. Diabetic retinopathy. II. Comparison of disease remission induced by various degrees of pituitary ablation by Y90.
    Joplin GF; Oakley NW; Hill DW; Kohner EM; Fraser TR
    Diabetologia; 1967 Aug; 3(4):406-12. PubMed ID: 5620799
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of grave diabetic retinopathy by intrahypophyseal implantation of radioactive yttrium].
    Jauregui GR; Scornavachi JC; Betti O
    Medicina (B Aires); 1967; 27(1):43-6. PubMed ID: 5594904
    [No Abstract]   [Full Text] [Related]  

  • 19. Yttrium 90 needle implantation in diabetes: correlation between degree of hypopituitarism and retinopathy response.
    Joplin GF; Hill DW; Oakley NW; Kohner E; Frazer R
    Proc R Soc Med; 1967 Feb; 60(2):149. PubMed ID: 6018838
    [No Abstract]   [Full Text] [Related]  

  • 20. The pituitary gland and its ablation using radioactive ytrrium.
    Yule A
    Radiography; 1974 Feb; 40(470):30-6. PubMed ID: 4816535
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.